Executive readout · one minute
Webcast research workspace
Read the call alongside every captured source. 8-K earnings release, 10-K stay in one workspace.
IKT
$1.91
-1.55%
IKT
· Inhibikase Therapeutics, Inc.
$1.91
-0.03 (-1.55%)
At close · Oct 8
Return incl. dividend (before tax)
Market Cap
$266.51M
Shares
139.54M
Volume · Oct 8
417.26K
Avg daily vol (3M)
652.47K
All webcasts
Earnings call · FY2024 Q4
Inhibikase Therapeutics, Inc. (IKT) Q4 2024 Earnings Call
Research coverage
2 live sources
Open each available source without leaving this research workspace.
Revenue · derived Q4
$0
-100% YoY
Net income · derived Q4
-$12.13M
Research materials
Open the source you need; every reader stays inside this workspace.
SEC filing · Item 2.02
8-K earnings release
Filed Mar 27, 2025 · complete as-filed document
SEC periodic report
10-K report
Filed Apr 25, 2025 · complete as-filed document